$63.93
-0.33-0.51%
Last update: Nov 11, 11:05 AM
TG Therapeutics Inc
TGTXNASDAQ
The average analyst price target for TG Therapeutics is $53.08, 17.0% below the current price. Of 8 analysts, 6 rate it Buy, 1 Hold and 1 Sell. Targets range from $20 to $86. The latest change came on Nov 10, 2026, when Evercore ISI Group lowered its price target on TG Therapeutics from $73 to $71 and kept an Outperform rating.
Price Target Range — 11 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months
